Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ebmBCfbwoceUynhRKTSz

  ADVERTISEMENT  
December 4, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Researchers to study potential of cord blood to stop diabetes
    Researchers at The Children's Hospital at Westmead in Australia are preparing to conduct a five-year study that will explore whether cord blood can save insulin-producing cells from the immune system to prevent the development of type 1 diabetes in children. The study will use stored umbilical cord blood and will involve children with a close family member who has type 1 diabetes. The Australian/Australian Associated Press (tiered subscription model) (12/4) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Quotient is on a roll with new FDA approvals & GPO contracts
More good news from Quotient! Not only do we have FDA-approved Reagent Red Blood Cells products, but also just approved Rare Antisera, including Anti-s and Anti-Wra. We also have new 3-yr agreements with Premier Inc. and the General Services Administration. Great products and value from the one manufacturer focused on manual testing. Contact us today.

  Science & Health 
  • H5N1 science grant draft plan meets with mixed reviews
    A federal government draft plan, which suggests that some H5N1 avian influenza virus research grant requests should be subjected to special reviews, has received mixed reactions from researchers. The plan was unveiled in an attempt to establish a framework for how federal agencies will weigh funding requests. Some scientists conducting influenza studies say the proposal could pose funding obstacles to a subset of potentially helpful studies. ScienceMag.org/Science Insider blog (11/30) LinkedInFacebookTwitterEmail this Story
  • CDC warns of early, severe flu season
    CDC officials announced Monday that the 2012-13 flu season has started nearly a month earlier than expected, with influenza A (H3N2) being this year's dominant strain, and they said this could be a bad year for flu. However, the influenza vaccine this year is a 90% match for the samples examined by the agency, officials said. "My advice is: Get the vaccine now," said infectious diseases specialist Dr. James Steinberg of Emory University. The Boston Globe/The Associated Press (tiered subscription model) (12/4), Family Practice News (12/3) LinkedInFacebookTwitterEmail this Story
  • Islet transplant may curb atherosclerosis risk in type 1 diabetes
    A study in Diabetes Care showed that type 1 diabetes patients who underwent pancreatic islet transplantation attained significant reductions in carotid artery thickness at 12 months, and the decline continued for up to 50 months after the procedure. Researchers said the surgery could help cut the risk of atherosclerosis by lowering hemoglobin A1c levels in patients. DailyRx.com (12/1) LinkedInFacebookTwitterEmail this Story
  • Cell transplant improves function in monkeys with Parkinson's
    Transplants of bone marrow stem cells safely improved motor skills in macaque monkeys with Parkinson's disease, according to a Japanese study published in the Journal of Clinical Investigation. In the study, the cells were derived from the monkeys' own bone marrow, so there was no risk of tissue rejection. The researchers said the method "may expand the availability of cell sources for cell-based therapies for patients with Parkinson's disease." Los Angeles Times/Science Now blog (tiered subscription model) (12/3) LinkedInFacebookTwitterEmail this Story
 
  ADVERTISEMENT  
Clinical Research: Understanding the Methodology Toolbox
Clinical Research: Understanding the Methodology Toolbox compiles articles of evidence-based research for use as an educational resource for those involved in clinical research, healthcare professionals and trainees in transfusion medicine and other medical specialties. Now in the AABB Marketplace.

  Emerging Trends 
  Industry News & Practice 
  • N.Y. hospitals reduce infection rates, data show
    New York state data showed rates of hospital-acquired infections are declining, except for cases of C. difficile, which frequently is found in ICUs. Central line-associated infection rates improved by 41% statewide, but the state's overall infection rates still are higher than the national average, data showed. Times Union (Albany, N.Y.) (11/30) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Ivera's tool to disinfect IV device tips gets FDA OK
    The FDA has given Ivera Medical 510(k) clearance to market its line of disinfection tools called Curos Tips. The technology is intended to offer clinicians an affordable and safer means of disinfecting male luer connectors on devices used to administer intravenous drugs. BeckersASC.com (12/3) LinkedInFacebookTwitterEmail this Story
  • FDA creates collaborative partnership with medical device makers
    The FDA and medical device makers formed a nonprofit organization, the Medical Device Innovation Consortium, to work with one another and with patient advocacy groups, CMS, foundations and academia to speed device approvals while protecting patients. "I know there will be real advances and new approaches that will emerge from it," said FDA Commissioner Dr. Margaret Hamburg. Medtronic, Boston Scientific, Becton Dickinson, Abiomed and Cyberonics are among the medical device companies participating in the consortium. Reuters (12/3) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: 2 sets of proposed standards available for comment
    The public comment period for the proposed draft "Standards for Immunohematology Reference Laboratories," eighth edition, and draft "Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens," second edition, will conclude Dec. 28. The Immunohematology Reference Laboratory Standards Program Unit and the Molecular Testing Standards Program Unit are encouraging all interested individuals to submit their comments. The drafts are available on the AABB website. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Click here to view more job listings.

  SmartQuote 
It is astonishing what force, purity and wisdom it requires for a human being to keep clear of falsehoods."
--Margaret Fuller,
American journalist and women's rights activist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information